Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Kan

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
Gene Therapy|May 9, 2008
Correction of the disease phenotype in the mouse model of Stargardt disease by lentiviral gene therapyJ Kong, S-R Kim, K Binley, et al.
Gene Therapy|March 31, 2006
EIAV vector-mediated delivery of endostatin or angiostatin inhibits angiogenesis and vascular hyperpermeability in experimental CNVK S Balaggan, K Binley, M Esapa, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
Gene Therapy|May 9, 2008
Correction of the disease phenotype in the mouse model of Stargardt disease by lentiviral gene therapyJ Kong, S-R Kim, K Binley, et al.
Gene Therapy|March 31, 2006
EIAV vector-mediated delivery of endostatin or angiostatin inhibits angiogenesis and vascular hyperpermeability in experimental CNVK S Balaggan, K Binley, M Esapa, et al.
Pageof 3